Beta-Amyloid (11-25) – 1 mg

Overview

Beta-Amyloid (11-25) is a highly studied peptide fragment that plays a crucial role in the formation of amyloid fibrils, which are associated with amyloidosis. This particular amino acid sequence comprises residues 11 to 25 of the beta-amyloid protein and exhibits the ability to form well-organized fibrils under in vitro conditions. These fibrils share structural similarities with those that contribute to pathological conditions in human diseases.

Key Features

• Forms structurally organized amyloid fibrils in vitro
• Similarities to pathogenic amyloid structures
• Facilitates research into aggregation mechanisms
• Ideal for studies related to neurodegenerative diseases
• Available in a 1 mg package for convenient use

Specifications

FAQ

What research applications is Beta-Amyloid (11-25) suitable for?

This peptide is particularly useful for studies related to neurodegenerative diseases, allowing researchers to investigate amyloid fibril formation and the underlying mechanisms of aggregation.

How does Beta-Amyloid (11-25) relate to amyloidosis?

Beta-Amyloid (11-25) mimics the pathogenic amyloid structures found in amyloidosis, making it a valuable tool for understanding the disease’s progression and potential treatments.

Where can I find more peptide products?

You can explore our extensive selection of peptides hereincluding other research materials like the PKG Substrate and Autocamtide-2.

For those looking to deepen their understanding of protein interactions, consider our CREBtidewhich offers unique labeling capabilities. Dive into your research today with Beta-Amyloid (11-25), a peptide that provides key insights into amyloid structure and behavior, paving the way for innovative studies in therapeutic development.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]